Literature DB >> 10439174

Cognitive impairment in patients with renal failure is associated with multiple-infarct dementia.

P Lass1, J R Buscombe, M Harber, A Davenport, A J Hilson.   

Abstract

PURPOSE: Patients undergoing long-term renal replacement therapy (such as dialysis) have an increased risk for significant cognitive impairment, which may result in memory problems and subsequently missed attendance at dialysis. The aim of this study was to try to identify any abnormalities of cerebral perfusion that could explain a patient's cognitive impairment and to determine if the pattern of these abnormalities would suggest a cause.
MATERIALS AND METHODS: 17 patients (13 men; mean age, 60 years; age range, 29-74 years) in end-stage renal failure or on dialysis had SPECT imaging 10 minutes after injection of 550 MBq (15 mCi) Tc-99m HMPAO. Two of the patients had a history of previous stroke. Other risk factors for stroke were noted in most of the patients (hypertension in 10 patients, smoking or former smoking in 10 patients, and cardiac atherosclerosis in 7 patients). In all patients, attenuation correction was applied and the images were reconstructed into three sets of orthogonal slices. Activity in the frontal and temporal lobes was compared by quantification against the ipsilateral and contralateral cerebellum.
RESULTS: Discrete cortical defects consistent with infarcts were seen in 14 patients. The mean right and left frontal-to-cerebellar ratio was 0.837 (SD, 0.09) and 0.837 (SD, 0.08), respectively. This was not significantly different from the right and left temporal-to-cerebellar ratios of 0.843 (SD, 0.07) and 0.848 (SD, 0.07), respectively. Both were within normally accepted ranges.
CONCLUSIONS: Patients in end-stage renal failure who also had cognitive impairment appear to have a high number of cortical defects consistent with infarcts (suggesting a multiple-infarct type of dementia). There was no evidence of Alzheimer-type dementia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439174     DOI: 10.1097/00003072-199908000-00003

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

1.  Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients.

Authors:  Akhil Sharma; Jonathan Yabes; Saleem Al Mawed; Christine Wu; Carol Stilley; Mark Unruh; Manisha Jhamb
Journal:  Am J Nephrol       Date:  2016-11-01       Impact factor: 3.754

2.  Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.

Authors:  Yin Ting Cheung; Michelle N Edelmann; Daniel A Mulrooney; Daniel M Green; Wassim Chemaitilly; Neena John; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-06-26       Impact factor: 4.254

Review 3.  Systematic review of structural and functional neuroimaging findings in children and adults with CKD.

Authors:  Divya G Moodalbail; Kathryn A Reiser; John A Detre; Robert T Schultz; John D Herrington; Christos Davatzikos; Jimit J Doshi; Guray Erus; Hua-Shan Liu; Jerilynn Radcliffe; Susan L Furth; Stephen R Hooper
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 8.237

4.  Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC.

Authors:  Elizabeth H Corder; John F Ervin; Evelyn Lockhart; Mari H Szymanski; Donald E Schmechel; Christine M Hulette
Journal:  J Biomed Biotechnol       Date:  2005-06-30

5.  Neurological disorders in a murine model of chronic renal failure.

Authors:  Jean-Marc Chillon; François Brazier; Philippe Bouquet; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2014-01-03       Impact factor: 4.546

Review 6.  The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.

Authors:  Maryam Assem; Mathilde Lando; Maria Grissi; Saïd Kamel; Ziad A Massy; Jean-Marc Chillon; Lucie Hénaut
Journal:  Toxins (Basel)       Date:  2018-07-22       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.